Synthesis of Analogues of Congo Red and Evaluation of Their Anti-Prion Activity

No cure as of yet exists for any of the transmissible spongiform encephalopathies. In this paper, we describe the synthesis of analogues of Congo red and evaluation against a cellular model of infection, the SMB (scrapie mouse brain) persistently infected cell line, for their ability to inhibit the infectivity of the abnormal form of prion protein (PrP-res). The compounds have also been tested for their ability to inhibit the polymerization of PrP^C by PrP-res. A number of analogues showed inhibition of PrP-res infectivity at nanomolar concentrations. Several analogues show promise; the most active compound, <BO>2a</BO>, inhibits the formation of PrP-res in SMB cells with an EC<INF>50</INF> of 25−50 nM.